VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ITGR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ITGRInteger Holdings Corporation
$91.90$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksITGRFinancials

Integer Holdings Corporation (ITGR) Financials

27Y historyFree accessUpdated daily

Revenue growth has decelerated significantly to 0.8% in 2026Q1, while gross margins have compressed from a 27.5% peak in 2024Q2 to 24.9%.

ITGR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue1.85B1.85B1.72B1.56B1.33B1.22B1.07B1.26B1.22B1.14B1.08B800.41M687.79M663.95M646.18M568.82M533.42M521.82M546.64M318.75M271.14M241.1M200.12M216.37M167.3M135.57M97.79M79.23M
Revenue Growth %6.01%7.57%10.35%16.85%9.02%13.75%-14.68%3.55%6.95%5.63%34.37%16.38%3.59%2.75%13.6%6.64%2.22%-4.54%71.5%17.56%12.46%20.48%-7.51%29.33%23.4%38.64%23.42%-
Cost of Goods Sold1.42B1.42B1.26B1.14B984.63M884.11M787.74M903.08M852.35M782.07M737.82M542.29M456.13M444.63M444M388.47M359.84M355.4M390.86M202.72M168.7M151.54M119.4M126.54M96.4M74.72M48.97M41.06M
COGS % of Revenue-76.94%73.13%73.55%73.96%72.4%73.38%71.78%70.15%68.84%68.6%67.75%66.32%66.97%68.71%68.29%67.46%68.11%71.5%63.6%62.22%62.86%59.66%58.48%57.62%55.11%50.07%51.82%
Gross Profit431.27M425.81M461.18M411.52M346.65M336.97M285.71M355.01M362.67M354.01M337.68M258.12M231.66M219.31M202.18M180.35M173.58M166.42M155.79M116.03M102.44M89.55M80.72M89.83M70.9M60.86M48.82M38.18M
Gross Margin %23.31%23.06%26.87%26.45%26.04%27.6%26.62%28.22%29.85%31.16%31.4%32.25%33.68%33.03%31.29%31.71%32.54%31.89%28.5%36.4%37.78%37.14%40.34%41.52%42.38%44.89%49.93%48.18%
Gross Profit Growth %--7.67%12.07%18.71%2.87%17.94%-19.52%-2.11%2.44%4.84%30.82%11.42%5.63%8.47%12.1%3.9%4.3%6.82%34.27%13.26%14.39%10.94%-10.14%26.7%16.5%24.65%27.88%-
Operating Expenses238.69M216.54M252.95M248.2M233.97M201.26M165.09M197.38M207.11M228.36M244.76M244.97M156M157.97M177.4M118.65M114.09M149.45M118.66M79.91M69.08M72.67M53.78M51.63M44.23M38.48M34.42M25.73M
OpEx % of Revenue-11.73%14.74%15.95%17.58%16.48%15.38%15.69%17.05%20.1%22.76%30.61%22.68%23.79%27.45%20.86%21.39%28.64%21.71%25.07%25.48%30.14%26.88%23.86%26.44%28.38%35.2%32.47%
Selling, General & Admin176.93M162.59M184.33M171.47M157.36M141.69M137.21M138.88M142.45M143.07M134.38M98.2M88.39M88.97M80.99M72.55M64.51M70.29M72.63M50M38.78M50.1M31.3M31.42M24.37M18.17M11.47M9.88M
SG&A % of Revenue-8.81%10.74%11.02%11.82%11.6%12.78%11.04%11.72%12.59%12.49%12.27%12.85%13.4%12.53%12.75%12.09%13.47%13.29%15.69%14.3%20.78%15.64%14.52%14.57%13.41%11.73%12.47%
Research & Development51.54M46.35M53.42M61.97M59.76M51.98M48.47M46.53M48.6M48.85M47.9M52.99M58.97M62.65M62.85M45.51M45.02M33.56M31.44M29.91M24.23M18.73M18.48M16.99M14.44M12.57M9.94M9.34M
R&D % of Revenue-2.51%3.11%3.98%4.49%4.26%4.52%3.7%4%4.3%4.45%6.62%8.57%9.44%9.73%8%8.44%6.43%5.75%9.38%8.93%7.77%9.23%7.85%8.63%9.28%10.17%11.79%
Other Operating Expenses3.13M7.6M15.2M14.76M16.85M7.58M-20.58M11.96M16.06M36.44M62.48M93.78M8.64M6.36M0593K4.56M11.09M14.58M06.07M3.84M4M3.22M5.42M7.73M13.01M6.51M
Operating Income192.57M209.27M208.24M163.32M112.68M135.71M120.61M157.63M155.56M125.65M92.92M13.15M75.65M61.34M68.7M61.7M68.99M1.05M34.89M20.02M22.38M16.89M26.94M38.2M26.66M22.38M14.4M12.45M
Operating Margin %10.41%11.33%12.13%10.5%8.46%11.11%11.24%12.53%12.8%11.06%8.64%1.64%11%9.24%10.63%10.85%12.93%0.2%6.38%6.28%8.25%7%13.46%17.66%15.94%16.51%14.73%15.71%
Operating Income Growth %-0.49%27.5%44.95%-16.97%12.52%-23.49%1.34%23.8%35.22%606.85%-82.62%23.34%-10.71%11.35%-10.57%6483.4%-97%74.3%-10.53%32.51%-37.32%-29.48%43.26%19.12%55.44%15.67%-
EBITDA328.42M335.22M317.95M260.31M203.57M217.3M199.94M235.53M237.09M206.83M165.79M57.78M112.85M97.31M114.53M109.39M115.44M48.28M80.28M45.86M41.69M36.6M41.77M51.38M38.76M36.63M27.41M23.81M
EBITDA Margin %17.75%18.15%18.52%16.73%15.29%17.8%18.63%18.72%19.51%18.21%15.42%7.22%16.41%14.66%17.72%19.23%21.64%9.25%14.69%14.39%15.37%15.18%20.88%23.75%23.17%27.01%28.03%30.05%
EBITDA Growth %-1.84%5.43%22.14%27.87%-6.32%8.69%-15.11%-0.66%14.63%24.75%186.94%-48.8%15.98%-15.04%4.7%-5.24%139.12%-39.86%75.04%10.02%13.88%-12.38%-18.69%32.54%5.84%33.62%15.11%-
D&A (Non-Cash Add-back)135.85M125.95M109.71M96.99M90.9M81.59M79.32M77.89M81.54M81.18M72.87M44.63M37.2M35.97M45.84M47.7M46.45M47.23M45.38M25.84M19.31M19.72M14.84M13.18M12.1M14.24M13.01M11.36M
EBIT192.57M209.27M223.23M178.72M130.85M143.06M103.66M169.6M171.62M162.71M155.4M106.92M93.42M76.27M68.7M65.32M67.84M1.89M40.47M35.99M33.36M16.89M26.94M38.2M26.66M22.38M14.4M12.45M
Net Interest Income-37.98M-42.31M-56.37M-53.37M-37.27M-31.63M-38.22M-52.55M-99.31M-63.97M-68.33M-33.51M-4.25M-11.26M-18.05M-16.91M-18.51M-19.75M-19.24M-253K00000000
Interest Income000000000000001K21K10K324K711K7.05M00000000
Interest Expense37.98M42.31M56.37M53.37M37.27M31.63M38.22M52.55M99.31M63.97M68.33M33.51M4.25M11.26M18.05M16.93M18.52M20.07M13.17M7.3M000003.59M00
Other Income/Expense-33.83M-83.87M-60.67M-57.94M-44M-34.65M-34.41M-52.44M-94.44M-76.39M-64.76M-28.85M925K-12.5M-61.97M-13.31M-19.67M-19.23M-7.59M8.67M-15.9M-1.42M-3.21M-4.88M-5.7M-3.85M-12.77M-14.76M
Pretax Income158.75M125.4M147.56M105.38M68.68M101.06M86.21M105.19M61.12M49.26M28.16M-15.7M76.58M48.84M6.73M48.39M49.33M-18.18M27.3M28.69M23.53M15.46M23.73M33.32M20.96M18.53M1.63M-2.31M
Pretax Margin %8.58%6.79%8.6%6.77%5.16%8.28%8.03%8.36%5.03%4.34%2.62%-1.96%11.13%7.36%1.04%8.51%9.25%-3.48%4.99%9%8.68%6.41%11.86%15.4%12.53%13.67%1.67%-2.92%
Income Tax16.95M22.57M26.51M16.24M8.93M8.04M8.95M13.97M14.08M-37.83M3.29M-8.11M21.12M12.57M11.53M15.27M16.19M-9.18M8.74M13.64M7.41M5.36M7.47M10.03M6.6M6.94M611K-605K
Effective Tax Rate %10.67%18%17.97%15.41%13%7.96%10.38%13.29%23.04%-76.79%11.67%51.63%27.58%25.74%171.31%31.55%32.82%50.48%32.03%47.54%31.48%34.64%31.5%30.1%31.5%37.45%37.46%26.15%
Net Income141.8M102.76M119.9M90.65M66.38M96.81M77.26M96.34M167.96M66.68M5.96M-7.59M55.46M36.27M-4.8M33.12M33.14M-9M18.56M15.05M16.13M10.11M16.26M23.29M14.36M8.6M-548K-2.27M
Net Margin %7.67%5.57%6.98%5.83%4.99%7.93%7.2%7.66%13.82%5.87%0.55%-0.95%8.06%5.46%-0.74%5.82%6.21%-1.72%3.4%4.72%5.95%4.19%8.12%10.76%8.58%6.34%-0.56%-2.87%
Net Income Growth %84.5%-14.29%32.26%36.57%-31.43%25.3%-19.8%-42.64%151.9%1018.59%178.5%-113.69%52.92%855.72%-114.49%-0.05%468.16%-148.5%23.32%-6.67%59.55%-37.83%-30.19%62.16%67.05%1668.8%75.88%-
Net Income (Continuing)141.8M102.83M121.05M89.14M59.75M93.02M77.26M91.22M47.03M87.09M24.88M-7.59M55.46M36.27M033.12M33.14M-9M18.56M15.05M16.13M10.11M16.26M23.29M14.36M11.59M1.02M-1.71M
Discontinued Operations0-68K-1.16M1.51M6.63M3.79M05.12M120.93M-20.41M-18.92M00000000000000000
Minority Interest0000000000000000000000000000
EPS (Diluted)4.122.893.402.691.962.802.332.775.152.080.19-0.292.141.43-0.201.401.40-0.390.810.670.730.460.661.050.680.43-0.04-0.18
EPS Growth %90.05%-15%26.39%37.24%-30%20.17%-15.88%-46.21%147.6%994.74%165.52%-113.55%49.65%815%-114.29%0%458.97%-148.15%20.9%-8.22%58.7%-30.3%-37.14%54.41%58.14%1231.58%78.89%-
EPS (Basic)-2.963.602.721.972.822.352.805.232.120.19-0.292.231.51-0.201.421.44-0.390.820.680.740.470.671.100.690.44-0.04-0.18
Diluted Shares Outstanding34.43M35.59M35.65M33.76M33.36M33.26M33.11M33.04M32.6M32.06M30.97M26.36M25.98M25.32M23.58M23.64M23.8M22.9M24.1M22.42M26.33M21.81M21.54M22.18M21.12M19.95M14.43M12.49M
Basic Shares Outstanding34.28M34.73M33.6M33.32M33.13M32.99M32.84M32.63M32.14M31.4M30.78M26.19M24.82M23.99M23.58M23.26M23.07M22.9M22.5M22.15M21.8M21.58M21.36M21.17M20.81M19.56M14.17M12.49M
Dividend Payout Ratio----------------------------

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Margin compression from costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Momentum Faces Headwinds

According to the latest quarterly financial data, Integer Holdings Corporation experienced a significant deceleration in top-line expansion, with revenue growth falling to 0.8% in 2026Q1 compared to the 11.1% peak observed in 2024Q4, suggesting a potential cooling in demand for its medical device component portfolio.

The sharp decline in year-over-year revenue growth indicates that the company may be struggling to maintain the momentum seen in previous periods. Investors should monitor whether this trend reflects broader OEM destocking cycles or a loss of competitive positioning within the high-complexity component market.

Structural Margin Erosion Remains Evident

As reported in recent income statements, Integer's gross margin has compressed from a high of 27.5% in 2024Q2 to 24.9% in 2026Q1, highlighting the company's limited ability to fully offset rising input costs through pricing power within its specialized medical device manufacturing segment.

The consistent contraction in gross margins suggests that the company's cost structure is highly sensitive to raw material price volatility. This trend warrants further investigation into whether the firm can successfully pass through inflationary pressures to its large-cap medtech OEM partners without sacrificing volume.

Operating Leverage Under Significant Pressure

Based on the provided financial figures, operating income dropped to $35.2M in 2026Q1 from a peak of $58.0M in 2024Q3, demonstrating that the company is currently failing to achieve the operating leverage necessary to scale profitability alongside its revenue base during this period of slower growth.

The inability to maintain operating margins while revenue growth decelerates implies that fixed costs are becoming a heavier burden on the bottom line. This suggests that management's current expense discipline may be insufficient to protect profitability in a more challenging macroeconomic environment.

Earnings Volatility Obscures Operational Performance

Financial statements reveal that net income has been highly inconsistent, swinging from a $22.5M loss in 2025Q1 to a $48.6M profit in 2025Q4, which indicates that non-operating items and accounting adjustments are significantly distorting the underlying quality of the company's reported earnings per share.

The wide variance in net income suggests that investors should focus more on core operating metrics rather than headline EPS figures. The recurring nature of restructuring and integration costs appears to be a persistent drag on earnings quality that warrants careful scrutiny by fundamental analysts.

Sustainability of Current Business Model

While management emphasizes its role as a critical partner to OEMs, the recent 5.57% net margin reported in financial filings suggests a fragile business model that may be overly reliant on M&A to mask the lack of organic margin expansion in its core manufacturing operations.

Short-term performance appears to be bolstered by inorganic growth, yet the underlying profitability remains thin and vulnerable to minor operational disruptions. The market may be overestimating the durability of these margins if the company cannot transition toward higher-value sub-assembly work to improve its competitive moat.

ITGR — Frequently Asked Questions

Quick answers to the most common questions about buying ITGR stock.

What was Integer Holdings Corporation's (ITGR) revenue in 2025?

For fiscal year 2025, Integer Holdings Corporation (ITGR) reported total revenue of $1.85B. This represents a 2230.4% increase compared to $79.2M in 1999.

Is Integer Holdings Corporation (ITGR) profitable?

Integer Holdings Corporation (ITGR) is profitable, generating $102.8M in net income for the fiscal year ending 2025 with a net profit margin of 5.6%.

What is Integer Holdings Corporation's operating profit margin?

Integer Holdings Corporation (ITGR) reported an operating income of $209.3M, resulting in an operating profit margin of 11.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Integer Holdings Corporation's gross profit and gross margin?

Integer Holdings Corporation (ITGR) generated $425.8M in gross profit for the year, representing a gross profit margin of 23.1%. This demonstrates the company's core pricing power and production efficiency.